These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 15231151)

  • 1. [Study on the immunogenicity and safety of 2 kinds of inactivated hepatitis A vaccine vaccinated in 1-3 years old children].
    Fu Y; Li ZL; Lao SJ; Wang M; Chen QB; Chen SJ; Li JG; Zhang Y
    Zhonghua Liu Xing Bing Xue Za Zhi; 2004 Jun; 25(6):551-2. PubMed ID: 15231151
    [No Abstract]   [Full Text] [Related]  

  • 2. Immunogenicity, safety, and interchangeability of two inactivated hepatitis A vaccines in Chilean children.
    Abarca K; Ibánez I; Perret C; Vial P; Zinsou JA
    Int J Infect Dis; 2008 May; 12(3):270-7. PubMed ID: 17988917
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunogenicity and safety of three consecutive lots of a new preservative-free inactivated hepatitis A vaccine (Healive): a double-blind, randomized and controlled trial.
    Jiang WP; Chen JT; Wang X; Wang YL; Liu Y; Chen WY; Xu WG; Qiu YZ; Yin WD
    Vaccine; 2008 Apr; 26(18):2297-301. PubMed ID: 18395305
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety and immunogenicity of concomitant vaccination with the cell-culture based Japanese Encephalitis vaccine IC51 and the hepatitis A vaccine HAVRIX1440 in healthy subjects: A single-blind, randomized, controlled Phase 3 study.
    Kaltenböck A; Dubischar-Kastner K; Eder G; Jilg W; Klade C; Kollaritsch H; Paulke-Korinek M; von Sonnenburg F; Spruth M; Tauber E; Wiedermann U; Schuller E
    Vaccine; 2009 Jul; 27(33):4483-9. PubMed ID: 19486955
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparing live attenuated and inactivated hepatitis A vaccines: an immunogenicity study after one single dose.
    Zheng H; Chen Y; Wang F; Gong X; Wu Z; Miao N; Zhang X; Li H; Chen C; Hou X; Cui F; Wang H
    Vaccine; 2011 Nov; 29(48):9098-103. PubMed ID: 21875638
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of immunogenicity between inactivated and live attenuated hepatitis A vaccines: a single-blind, randomized, parallel-group clinical trial among children in Xinjiang Uighur Autonomous Region, China.
    Liu XE; Wushouer F; Gou A; Kuerban M; Li X; Sun Y; Zhang J; Liu Y; Li J; Zhuang H
    Hum Vaccin Immunother; 2013 Jul; 9(7):1460-5. PubMed ID: 23571173
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The investigation on the safety and immunogenicity of inactived hepatitis A vaccine AVAXIM].
    Huang G; Wan Z; Li R
    Zhonghua Liu Xing Bing Xue Za Zhi; 2000 Aug; 21(4):287-8. PubMed ID: 11860802
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An open, prospective, randomized study comparing the immunogenicity and safety of two inactivated hepatitis A pediatric vaccines in toddlers, children and adolescents in China.
    Li RC; Li Y; Yi N; Huang L; Wan Z; Zhang Y; Rasuli A
    Pediatr Infect Dis J; 2013 Feb; 32(2):e77-81. PubMed ID: 23334341
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A comparative study on safety and immunogenicity of an inactivated hepatitis A vaccine in HBsAg carriers and healthy children].
    Chen J; Ren Y; Wu W; Ma S; Li S; Wang J; Kang W; Han L; Gao S; Zhang Y; Liu C
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2002 Dec; 16(4):380-1. PubMed ID: 12665912
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term clinical observation of the immunogenicity of inactivated hepatitis A vaccine in children.
    Bian GL; Ma R; Dong HJ; Ni HX; Hu FJ; Chen YR; Chen JQ; Zhou SY; Lin YX; Xu GZ
    Vaccine; 2010 Jul; 28(30):4798-801. PubMed ID: 20471440
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of virosome hepatitis A vaccine in young children in Nicaragua: randomized placebo-controlled trial.
    Mayorga Pérez O; Herzog C; Zellmeyer M; Loáisiga A; Frösner G; Egger M
    J Infect Dis; 2003 Sep; 188(5):671-7. PubMed ID: 12934183
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the safety and immunogenicity of live attenuated and inactivated hepatitis A vaccine in healthy Chinese children aged 18 months to 16 years: results from a randomized, parallel controlled, phase IV study.
    Ma F; Yang J; Kang G; Sun Q; Lu P; Zhao Y; Wang Z; Luo J; Wang Z
    Clin Microbiol Infect; 2016 Sep; 22(9):811.e9-811.e15. PubMed ID: 27345175
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical trial to evaluate immunogenicity and safety of inactivated hepatitis A vaccination starting at 2-month-old children.
    Kanra G; Yalçin SS; Ceyhan M; Yurdakök K
    Turk J Pediatr; 2000; 42(2):105-8. PubMed ID: 10936974
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interchangeability and tolerability of two inactivated hepatitis A vaccines in Chinese children.
    Zhang ZL; Zhu XJ; Wang X; Liang M; Sun J; Liu Y; Gao ZG; Wu JY; Dong XJ; Liu RK; Chen JT; Zhang YQ; Wang W; Zhang LP; Yin W
    Vaccine; 2012 Jun; 30(27):4028-33. PubMed ID: 22537990
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term immunity after two doses of inactivated hepatitis A vaccine, in Argentinean children.
    López EL; Contrini MM; Mistchenko A; Debbag R
    Pediatr Infect Dis J; 2010 Jun; 29(6):568-70. PubMed ID: 20195189
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Comparison of immunology effects between live attenuated hepatitis A vaccine and inactivated hepatitis A vaccine].
    Wang X; Meng Z; Li R
    Zhonghua Yi Xue Za Zhi; 2000 Jun; 80(6):422-4. PubMed ID: 11798797
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety and immunogenicity of an inactivated hepatitis A vaccine among HIV-infected subjects.
    Wallace MR; Brandt CJ; Earhart KC; Kuter BJ; Grosso AD; Lakkis H; Tasker SA
    Clin Infect Dis; 2004 Oct; 39(8):1207-13. PubMed ID: 15486846
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunogenicity and safety of an inactivated hepatitis A vaccine administered concomitantly with diphtheria-tetanus-acellular pertussis and haemophilus influenzae type B vaccines to children less than 2 years of age.
    Nolan T; Bernstein H; Blatter MM; Bromberg K; Guerra F; Kennedy W; Pichichero M; Senders SD; Trofa A; Collard A; Sullivan DC; Descamps D
    Pediatrics; 2006 Sep; 118(3):e602-9. PubMed ID: 16950952
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The study on the 0, 12 month vaccination schedule' of Healive inactivated hepatitis A vaccine in children].
    Ren YH; Chen JT; Wu WT; Gong XJ; Zhang YC; Xue WH; Ren YF; Han LJ; Kang WX; Li SP; Liu CB
    Zhonghua Liu Xing Bing Xue Za Zhi; 2003 Nov; 24(11):1013-5. PubMed ID: 14687502
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Immunogenicity and safety of three consecutive lots on an inactivated hepatitis A vaccine: a double-blind, immunogenicity and safety of three consecutive lots on a inactivated hepatitis A vaccine:a double-blind, randomized and controlled trial in children].
    Jiang WP; Wang YL; Chen WY; Xu WG; Chen JT; Wang X; Liu Y; Yin WD
    Zhonghua Liu Xing Bing Xue Za Zhi; 2008 Jun; 29(6):556-9. PubMed ID: 19040036
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.